FDA Inspection 1202279 — H. Henry Li, MD
The FDA completed an inspection of H. Henry Li, MD on March 24, 2023 in Chevy Chase, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 24, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chevy Chase, MD (United States)
Additional Details
Clinical BA/BE
Citations
| ID | CFR | Description |
|---|---|---|
| 7367 | 21 CFR 50.55(e)(2) | Two parents' permission: studies under Parts 50.53 - 50.54 |